A panel of epitope-specific antibodies detects protein domains distributed throughout human α-synuclein in Lewy bodies of Parkinson's disease

Journal of Neuroscience Research

Volumn 59, Issue 4, 2000, Pages 528-533

  Giasson, Benoit I ^a   Jakes, Ross ^b   Goedert, Michel ^b   Duda, John E ^a   Leight, Susan ^a   Trojanowski, John Q ^a   Lee, Virginia M Y ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^c HUP   (United States)

Author keywords

synuclein; Antibodies; Lewy body; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN;

AGED; ANTIBODY SPECIFICITY; ARTICLE; CASE REPORT; EPITOPE MAPPING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEWY BODY; MALE; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION;

AGED; ALPHA-SYNUCLEIN; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CROSS REACTIONS; EPITOPE MAPPING; HUMANS; LEWY BODIES; MALE; NERVE TISSUE PROTEINS; PARKINSON DISEASE; SUBSTANTIA NIGRA; SYNUCLEINS;

EID: 0034651575     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0     Document Type: Article

References (47)

1. Arawaka S, Saito H, Murayama S, Mori H. 1998. Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for α-synuclein. Neurology 51:887-889.
2. Arima K, Uéda K, Sunohara N, Arakawa K, Hirai S, Nakamura M, Tonozuka-Uehara H, Kawai M. 1998a. NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy. Acta Neurapathol 96:439-444.
3. Arima K, Uéda K, Sunohara N, Hirai S, Izumiyama Y, Tonozuka-Uehara H, Kawai M. 1998b. Immunoelectron-microscopic demonstration of NACP/α-synuclein -epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies. Brain Res 808:93-100.
4. Baba M, Nakajo S, Tu P, Tomita T, Nakaya K, Lee VMY, Trojanowski JQ, Iwatsubo T. 1998. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 152:879-884.
5. Bayer TA, Jakala P, Hartmann T, Havas L, McLean C, Culvenor JG, Li QX, Masters CL, Falkai P, Beyreuther K. 1999. alpha-Synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores. Neurosci Lett 266:213-216.
6. Buchman VL, Hunter HJA, Pinòn LGP, Thompson J, Privalova EM, Ninkina NN, Davies AM. 1998. Persyn, a member of the synuclein family, has a distinct pattern of expression in the developing nervous system. J Neurosci 18:9335-9341.
7. Conway KA, Harper JD, Lansbury PT. 1998. Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease. Nat Med 11:1318-1320.
8. Crowther RA, Jakes R, Spillantini MG, Goedert M. 1998. Synthetic filaments assembled from C-terminally truncated α-synuclein. FEBS Lett 436:309-312.
9. Davidson WS, Jonas A, Clayton DF, George JM. 1998. Stabilization of α-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem 273:9443-9449.
10. 53 to Thr on the physical and morphological properties of α-synuclein protein implicated in Parkinson's disease. FEBS Lett 440:67-70.
11. Forno LS. 1996. Neuropathology of Parkinson's disease. J Neuropath Exp Neurol 53:259-272.
12. George JM, Jin H, Woods WS, Clayton DF. 1995. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15:361-372.
13. Giasson BI, Uryu K, Trojanowski JQ, Lee VMY. 1999. Mutant and wild type human α-synucleins assemble into elongated filaments with distinct morphologies in vitro. J Biol Chem 274:7619-7622.
14. Goedert M. 1997. The awakening of α-synuclein. Nature 388:232-233.
15. Hong L, Ko HW, Gwag BJ, Joe E, Lee S, Kim YT, Suh Y-H. 1999. The cDNA cloning and ontogeny of mouse α-synuclein. NeuroReport 9:1239-1243.
16. Irizarry MC, Kim T-W, McNamara M, Tanzi RE, George JM, Clayton DF, Hynian BT. 1996. Characterization of the precursor protein of the non-Aβ component of senile plaques (NACP) in the human central nervous system. J Neuropath Exp Neurol 55:889-895.
17. Irizarry MC, Growdon W, Gomez-Isla T, Newell K, George JM, Clayton DF, Hyman BT. 1998. Nigral and cortical Lewy bodies and dystrophic nigral neuntes in Parkinson's disease and cortical Lewy body disease contain α-synuclein immunoreactivity. J Neuropathol Exp Neurol 57: 334-337.
18. Iwai A, Masliah E, Yoshinioto M, Ge N, Flanagan L, Rohan de Silva HA, Kittel A, Saitoh T. 1995a. The precursor protein of non-Aβcomponent of Alzheinier's disease amyloid is a presynaptic protein of the central nervous system. Neuron 14:467-475.
19. Iwai A, Yoshinioto M, Masliah E, Saitoh T. 1995b. Non-Aβ component of Alzheimer's disease amyloid (NAC) is amyloidogenic. Biochemistry 34:10139-10145.
20. Jakes R, Spillantini MG, Goedert M. 1994. Identification of two distinct synuclems from human brain. FEBS Lett 345:27-32.
21. Jakes R, Crowther RA, Lee VMY, Trojanowski JQ, Iwatsubo T, Goedert M. 1999. Epitope mapping of LB509, a monoclonal antibody directed against human α-synuclein. Neurosci Lett 269:13-16.
22. Jensen PH, Nielsen MS, Jakes R, Dotti CG, Goedert M. 1998. Binding of α-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. J Biol Chem 273:26292-26294.
23. Ji H, Liu YE, Jia T, Wang M, Liu J, Xiao G, Joseph BK, Rosen C, Shi YE. 1997. Identification of a breast cancer-specific gene, BCSG1, by differential cDNA sequencing. Cancer Res 57:759-764.
24. Krüger R, Kuhn WMT, Woitalla D, Graeber M, Kösel S, Przuntek H, Epplen JT, Schöls L, Riess O. 1998. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat Genet 18:106-108.
25. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
26. Maroteaux L, Campanelli JT, Scheller RH. 1988. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 8:2804-2815.
27. Nakajo S, Omata K, Aiuchi T, Shibayama T, Okahashi I, Ochiai H, Nakai Y, Nakaya K, Nakamura Y. 1990. Purification and characterization of a novel brain-specific 14-kDa protein. J Neurochem 55:2031-2038.
28. Nakajo S, Shioda S, Nakai Y, Nakaya K. 1994. Localization of phosphoneuroprotein 14 (PNP 14) and its mRNA expression in rat brain determined by immunocytochemistry and in situ hybridization. Mol Brain Res 27:81-86.
29. Narhi L, Wood SJ, Steavenson S, Jiang Y, Wu GM, Anafi D, Kaufman SA, Martin F, Sitney K, Denis P, Louis J-C, Wypych J, Biere AL, Citron M. 1999. Both familial Parkinson's disease mutations accelerate α-synuclein aggregation. J Biol Chem 274:9843-9846.
30. Papadimitriou A, Veletza V, Hadjigeorgiou GM, Patrikiou A, Hirano M, Anastasopoulos I. 1999. Mutated α-synuclein gene in two Greek kindreds with familial PD: incomplete penetrance. Neurology 52:651-654.
31. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Runebstein J, Boyer R, Stenroos, ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WCJ, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL. 1997. Mutations in the α-synuclein gene identified in families with Parkinson's disease. Science 276:2045-2047.
32. Schmidt ML, Lee VMY, Hurtig H, Trojanowski JQ. 1988. Properties of antigenic determinants that distinguish neurofibrillary tangles in progressive supranuclear palsy and Alzheinier's disease. Lab Invest 59: 460-466.
33. Shibayama-Imazu T, Okahashi I, Omata K, Nakajo S, Ochiai H, Nakai Y, Hama T, Nakamura Y, Nakaya K. 1993. Cell and tissue distribution and development change of neuron specific 14 kDa protein (phosphoneuroprotein 14). Brain Res 622:17-25.
34. Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Jakes R, Goedert M. 1997. α-synuclein in Lewy bodies. Nature 388:839-840.
35. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. 1998a. α-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 95: 6469-6473.
36. Spillantini MC, Crowthier KA, Jakes R, Cairns NJ, Lantos PL, Goedert M. 1998b. Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett 251:205-208.
37. Surguchov A, Surgucheva I, Solessio E, Baehr W. 1999. Synoretin-a new protein belonging to the synuclem family. Mol Cell Neurosci 13:95-103.
38. Takeda A, Hashuimoto M, Mallory M, Sundsumo M, Hansen L, Sisk A, Masliah E. 1998a. Abnormal distribution of the non-Aβ component of Alzheimer's disease amyloid precursor/β-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment. Lab Invest 78:1169-1177.
39. Takeda A, Mallory M, Sundsumo M, Honer W, Hansen L, Masliah E. 1998b. Abnormal accumulation of NACP/α-synuclein in neurodegenerative disorders. Am J Pathol 152:367-372.
40. Tobe T, Nakajo S, Tanaka A, Mitoya A, Omata K, Nakaya K, Tomita M, Nakamura Y. 1992. Cloning and characterization of the cDNA encoding a novel brain-specific 14-kDa protein. J Neurochem 59:1624-1629.
41. Trojanowski JQ, Schuck T, Schmidt ML, Lee V-MY. 1989. Distribution of tau proteins in the normal human central and peripheral nervous system. J Histochem Cytochem 37:209-215.
42. Tu P, Calvin JE, Baba M, Giasson B, Tomita T, Leigth S, Nakajo S, Iwatsubo T, Trojanowski JQ, Lee VMY. 1998. Gial cytoplismic inclusions in white matter oligodendrocytes of multple system atrophy brain contain insoluble α-synuclein. Ann Neurol 44:415-422.
43. Uéda K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M, Otero DAC, Kondo J, Ihara Y, Saitoh T. 1993. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer's disease. Proc Natl Acad Sci USA 90:11282-11286.
44. Wakabayashi K, Matsumoto K, Takayama K, Yoshimoto M, Takahashi H. 1997. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease. Neurosci Lett 239: 45-18.
45. Wakabayashi K, Hayashi S, Kakita A, Yamada M, Toyoshima Y, Yoshimoto M, Takahashi H. 1998a. Accumulation of α-synuclein is a cytopathological feature common to Lewy body disease and multiple system atropy. Acta Neuropathol 96:445-452.
46. Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H. 1998b. α-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 249:180-182.
47. Weinreb PH, Zhen W, Poon AW, Conway KA, Lansbury PT. 1996. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35:13709-13715.